Pomerleau-Normandin D, Heisz M, Tanguay F
Centre for Biosecurity, Public Health Agency of Canada, Ottawa, ON.
Can Commun Dis Rep. 2018 Nov 1;44(11):297-304. doi: 10.14745/ccdr.v44i11a05.
Under Canada's and , the Public Health Agency of Canada (PHAC) is mandated with monitoring laboratory incident notifications through the Laboratory Incident Notification Canada (LINC) surveillance system. The year 2017 marks the second complete year of data.
To describe the laboratory exposure and laboratory-acquired infection incidents that occurred in Canada in 2017 by sector, human pathogens and toxins involved, number of affected persons, incident type and root causes.
The incidents included in the analysis occurred between January 1 and December 31, 2017. They were reported by laboratories with active licences to PHAC through the LINC surveillance system. Microsoft Excel 2010 was used for basic descriptive statistics.
A total of 44 exposure and laboratory-acquired infection incidents were reported to the LINC in 2017. Compared by sector and their respective shares of licences, the number of incidents was highest in the academic and hospital sectors compared with government laboratories and private industry. Altogether 118 people were exposed for an average of 2.7 people per incident (range of 1-29). There were no reports of secondary exposure. Six exposure incidents (14%) led to "suspected" (n=5) or confirmed (n=1) cases of laboratory-acquired infection. Although overall, risk group (RG)2 human pathogens and toxins were involved in the majority of incidents (n=23; 52%), (n=4; 9%) and (n=3; 7%) were the most frequently involved in reported exposure incidents. These two pathogens are both RG3 and security-sensitive biological agents (SSBAs). An average of 2.3 root causes were identified per incident (n=101). Problems with standard operating procedures (SOPs) and human error were the two most common causes.
The incidence of laboratory exposure incidents was relatively low in 2017. The most common route of exposure was through inhalation and the most common root causes were problems with SOPs and human error. Since this is a new surveillance system, baseline estimates are still being established.
根据加拿大的[相关法规],加拿大公共卫生署(PHAC)负责通过加拿大实验室事件通报(LINC)监测系统监测实验室事件通报情况。2017年是有完整数据的第二年。
按部门、所涉及的人类病原体和毒素、受影响人数、事件类型及根本原因,描述2017年在加拿大发生的实验室暴露和实验室获得性感染事件。
纳入分析的事件发生在2017年1月1日至12月31日之间。它们由持有有效许可证的实验室通过LINC监测系统向PHAC报告。使用Microsoft Excel 2010进行基本描述性统计。
2017年LINC共收到44起暴露和实验室获得性感染事件报告。按部门及其各自的许可证份额比较,学术和医院部门的事件数量高于政府实验室和私营企业。共有118人暴露,平均每次事件2.7人(范围为1 - 29人)。无二次暴露报告。6起暴露事件(14%)导致“疑似”(n = 5)或确诊(n = 1)实验室获得性感染病例。虽然总体而言,风险组(RG)2人类病原体和毒素涉及大多数事件(n = 23;52%),但[具体病原体1](n = 4;9%)和[具体病原体2](n = 3;7%)是报告的暴露事件中最常涉及的。这两种病原体均为RG3和安全敏感生物制剂(SSBA)。每次事件平均确定2.3个根本原因(n = 101)。标准操作程序(SOP)问题和人为错误是两个最常见的原因。
2017年实验室暴露事件发生率相对较低。最常见的暴露途径是吸入,最常见的根本原因是SOP问题和人为错误。由于这是一个新的监测系统,仍在确定基线估计值。